Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Partnering Bootcamp Added to ChinaBio® Partnering Forum
The special afternoon program, called “Partnering Bootcamp: How to Partner with Global Pharma,” is designed to be a practical “how to” session for new or experienced entrepreneurs launching their life science business in China. The bootcamp will offer practical advice for protecting intellectual property and foster discussion on developing partnerships with international pharma.
“We are pleased to have the opportunity to host this special program to share our expertise in advising global life sciences companies on issues ranging from venture capital and private equity to IP strategy and partnering,” said Patrick Loofbourrow, a Shanghai Partner with Cooley LLP. “The bootcamp will jump start the week for delegates and may even change their long-term business agendas.”
Bootcamp speakers will discuss specific points on dealmaking in China, including what to expect from a partnering relationship and how to meet and impress potential partners.
The pre-conference program continues with “Optimizing your business in China” with Cooley LLP Partners Dr. Lila Hope and Dr. Nan Wu from Palo Alto/Shanghai and San Francisco/San Diego, respectively. The speakers will discuss the challenges in launching a life science business in China, from the first in-license at a company’s formation to partnering pipeline products.
Another session, “What to expect from a partnering relationship,” will cover what to look for in a partner in China and what those partners are looking for in return. The panel features speakers Greg B. Scott, President and Founder of ChinaBio® LLC, Dr. Jimmy Z. Zhang, Worldwide Licensing & Acquisitions with Merck & Co., Inc., and Dr. Hope from Cooley.
“Partnering is a critical part of business development and certainly is one of the most important steps your company will take. It should be carefully planned and executed,” said Zhang. “The key to China is in understanding the finer complexities ranging from licensing to co-development and distribution channels. This panel really echoes the theme of the conference; relationships are the key ingredient to creating a presence in China. ”
The focus on partnering continues in a third panel, “How to meet and impress potential partners,” which is designed to guide delegates in maximizing their experience at ChinaBio®Partnering Forum 2012. Speaker Martina Molsbergen, CEO of C14 Consulting Group, will review features of the partneringONE® system used at the conference. EBD Group's partneringONE® enables delegates to efficiently identify, meet and network with other attendees at the conference.
ChinaBio® Partnering Forum is the premier life science partnering event in China. Held in Suzhou, China, this year the event will attract biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering.
Online registration for the conference will close on May 17, 2012, 5:00 PM PDT, after which all registrations will be handled on site. Information on the conference and registration details can be found online at www.ebdgroup.com/cbpf/registration.